About
Peter Fedichev is a physicist-turned-biotech entrepreneur and the CEO/co-founder of Gero, a longevity biotechnology company using physics-based AI and human data to develop therapies for age-related diseases. He holds a Ph.D. in theoretical physics from the University of Amsterdam and has published more than 75 scientific papers. His public profile is centered on aging research, drug discovery, and biotech company-building, including collaborations announced by Gero with Pfizer and Chugai.
Areas of interest
longevitybiotechaging researchAImachine learningdrug discoverycomputational biologydigital biomarkershealth dataneurodegenerationphysics